Current Report Filing (8-k)
November 13 2017 - 6:32AM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT
REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): November 13, 2017
ENVISION HEALTHCARE CORPORATION
(Exact name of registrant as specified in its charter)
|
|
|
|
|
Delaware
|
|
001-37955
|
|
62-1493316
|
(State or other jurisdiction
of incorporation)
|
|
(Commission
File Number)
|
|
(IRS Employer
Identification No.)
|
|
|
1A Burton Hills Boulevard
Nashville, Tennessee
|
|
37215
|
(Address of principal executive offices)
|
|
(Zip Code)
|
(615)
665-1283
(Each registrants telephone number, including area code)
Not Applicable
(Former
name or former address, if changed since last report)
Check the
appropriate box below if the
Form 8-K
filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
|
☐
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
|
☐
|
Soliciting material pursuant to
Rule 14a-12
under the Exchange Act (17 CFR
240.14a-12)
|
|
☐
|
Pre-commencement
communications pursuant to
Rule 14d-2(b) under
the Exchange Act (17 CFR
240.14d-2(b))
|
|
☐
|
Pre-commencement
communications pursuant to
Rule 13e-4(c) under
the Exchange Act (17 CFR
240.13e-4(c))
|
Indicate by check mark whether the registrant is an emerging growth
company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule
12b-2
of the Securities Exchange Act of 1934
(§240.12b-2
of
this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 7.01.
|
Regulation FD Disclosure.
|
On November 13, 2017, Envision Healthcare Corporation, a Delaware
corporation (the Company) posted an investor presentation to its website, which will be discussed in meetings with investors. A copy of the presentation is furnished as Exhibit 99.1 to this Form
8-K.
Item 9.01.
|
Financial Statements and Exhibits.
|
(d)
Exhibits.
|
|
|
Exhibit
No.
|
|
Description of Exhibit
|
|
|
99.1
|
|
November 2017 Investor Update.
|
EXHIBIT INDEX
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, Envision Healthcare Corporation has duly caused this report to be signed
on its behalf by the undersigned hereunto duly authorized.
|
|
|
|
|
|
|
|
|
|
|
ENVISION HEALTHCARE CORPORATION
|
|
|
|
|
November 13, 2017
|
|
|
|
By:
|
|
/s/ Kevin D. Eastridge
|
|
|
|
|
Name:
|
|
Kevin D. Eastridge
|
|
|
|
|
Title:
|
|
Executive Vice President and Chief Financial Officer
|
ENVISION HEALTHCARE HOLDINGS, IN (NYSE:EVHC)
Historical Stock Chart
From Aug 2024 to Sep 2024
ENVISION HEALTHCARE HOLDINGS, IN (NYSE:EVHC)
Historical Stock Chart
From Sep 2023 to Sep 2024